Loading...
Loading...
Holder clone rankings through .
Among the 4 tracked institutional investors we monitor, KZIA (KAZIA THERAPEUTICS) is held with a combined value of $4.80M across 460,679 shares. The largest holder is Point72 Asset Management, L.P. with a position worth $2.30M. 1 fund increased its holdings. 2 funds reduced their position.
Total Institutional Value
$4.80M
Total Shares Held
460,679
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | $2.30M | 0.00% | -0.1% |
| 2 | CITADEL ADVISORS LLC | $1.68M | 0.00% | +513.8% |
| 3 | COOPERMAN LEON G | $479.75K | 0.01% | - |
| 4 | MILLENNIUM MANAGEMENT LLC | $342.53K | 0.00% | -64.8% |
As of the latest SEC 13F filings, Point72 Asset Management, L.P. is the largest institutional holder of KZIA with a position worth $2.30M, representing 0.00% of their portfolio. In total, 4 institutional investors hold KZIA with a combined value of $4.80M.
Institutional investors hold $4.80M worth of KZIA stock across 4 positions. The largest institutional holder is Point72 Asset Management, L.P. with $2.30M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For KZIA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
| — |
| 5.4% |
| 2026-10-02 |
| — | 19.6% | 2026-08-19 |
| — | 4.9% | 2026-08-14 |
| — | 4.6% | 2026-08-14 |
SEC Schedule 13D (activist) and 13G (passive) filings for KZIA. Filed when an investor acquires 5%+ ownership.
Last Close
$5.49
2026-11-18
YTD
+9.8%
4% of 52-week range